Detalhe da pesquisa
1.
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
; 179(4): 964-983.e31, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675502
2.
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Cell
; 180(1): 207, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31923397
3.
Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma.
Mol Cell Proteomics
; 20: 100123, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298159
4.
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
Cancer Cell
; 41(1): 139-163.e17, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563681
5.
Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Cancer Cell
; 41(9): 1586-1605.e15, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567170
6.
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Med Oncol
; 38(9): 105, 2021 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331598